ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HKMPY Hikma Pharmaceuticals plc (PK)

50.66
-0.87 (-1.69%)
13 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Hikma Pharmaceuticals plc (PK) USOTC:HKMPY OTCMarkets Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.87 -1.69% 50.66 49.63 51.63 52.10 50.65 52.10 1,516 21:01:21

Aldermore Appoints Pat Butler Chairman Upon Completion of FirstRand Takeover

13/12/2017 8:17am

Dow Jones News


Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Hikma Pharmaceuticals (PK) Charts.
   By Ian Walker 
 

Aldermore Group PLC (ALD.LN) said Wednesday that it will appoint Pat Butler as chairman once its 1.1 billion-pound ($1.47 billion) takeover by FirstRand Ltd. (FSR.JO) completes.

The specialist lender said Mr. Butler will become a non-executive director and chairman designate on Jan. 1, 2018. Danuta Gray will continue in her role as interim chairman until Mr. Butler's appointment, the company said, adding that she will then resume her role as senior independent director.

Aldermore said on Nov. 6 that it had accepted an offer of 313 pence a share from FirstRand. The deal was approved by the court and shareholders on Dec. 8.

Completion of the acquisition is still subject to certain conditions, and is expected in the first quarter of 2018.

Mr. Butler currently serves as an independent non-executive director of Bank of Ireland Group (BIRG.DB) and Bank of Ireland (U.K.), where he chairs the remuneration committee; of Hikma Pharmaceuticals (HIK.LN), where he is chairman of the audit committee; and of the Ardonagh Group, where he chairs the risk committee.

 

Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749

 

(END) Dow Jones Newswires

December 13, 2017 03:02 ET (08:02 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Hikma Pharmaceuticals (PK) Chart

1 Year Hikma Pharmaceuticals (PK) Chart

1 Month Hikma Pharmaceuticals (PK) Chart

1 Month Hikma Pharmaceuticals (PK) Chart

Your Recent History

Delayed Upgrade Clock